A Remarkable New Nutrient for Bone and Joint Health, Part 1
| Podcast |
|---|
|
|
|
Share:
 
|
Cyplexinol (Ostinol) is an oral Bone Morphogenetic Protein (BMP). It signals mesenchymal stem cells to differentiate into osteoblasts, the cells that build bone. James Scaffidi, CEO and founder of Zycal Bioceuticals, details the research behind Ostinol. How does it bypass the GI tract to deliver bone benefits? How does it promote healing of fractures? What’s the evidence that it’s beneficial for osteoporosis? Do studies support its use for osteoarthritis pain? Do its benefits extend to rheumatoid arthritis? What’s the optimal dosage of Ostinol? How long before users see results? Is it compatible with other bone-building or anti-inflammatory supplements? What about osteoporosis medications? What additional conditions are being explored as targets for Ostinol? Why is it that mainstream doctors haven’t yet embraced this therapy? Click Subscribe to the Intelligent Medicine Podcast for Free from your Favorite Podcast Provider
 |
 |
 |
 |
|
|
|
| Podcast |
|---|
|
|
|
Share:
|
|
|
|
|
|
|
|
|
|
|
|
Though we think of declining estrogen as the hallmark of menopause, it's actually common for…
Up to 12 percent of Americans have ulcers at some point in life. Peptic ulcers…
Gallbladder disease is a modern illness. An estimated 20 million Americans have gallbladder disease. The…
Q: My mother is otherwise healthy, takes no medications and walks daily for exercise, but she…
More mask misdirection (and some possible clarity): I’m finally getting a handle on this mask…
We are living in unprecedented and unpredictable times. It seems every day brings new recommendations…
Intelligent Medicine Radio Show for May 23, Part 1
NTFactor® with D3/K2 is a tasty, chewable wafer that helps restore your energy,* reduces fatigue*, and gives the additional benefit of vitamin D3 and K2 supplementation.
Recent studies have suggested that up to 50% of adults and children worldwide are vitamin D deficient. Vitamin D has multiple roles in the body, including:
